Evasion of innate immunity by parasitic protozoa

被引:278
作者
Sacks, D [1 ]
Sher, A [1 ]
机构
[1] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1038/ni1102-1041
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Parasitic protozoa are a major cause of global infectious disease. These eukaryotic pathogens have evolved with the vertebrate immune system and typically produce long-lasting chronic infections. A critical step in their host interaction is the evasion of innate immune defenses. The ability to avoid attack by humoral effector mechanisms, such as complement lysis, is of particular importance to extracellular parasites, whereas intracellular protozoa must resist killing by lysosomal enzymes and toxic metabolites. They do so by remodeling the phagosomal compartments in which they reside and by interfering with signaling pathways that lead to cellular activation. In addition, there is growing evidence that protozoan pathogens modify the antigen-presenting and immunoregulatory functions of dendritic cells, a process that facilitates their evasion of both innate and adaptive immunity.
引用
收藏
页码:1041 / 1047
页数:7
相关论文
共 99 条
[1]   THE INTERACTION OF LEISHMANIA SPECIES WITH MACROPHAGES [J].
ALEXANDER, J .
ADVANCES IN PARASITOLOGY, 1992, 31 :175-254
[2]   Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity [J].
Aliberti, J ;
Hieny, S ;
Sousa, CRE ;
Serhan, CN ;
Sher, A .
NATURE IMMUNOLOGY, 2002, 3 (01) :76-82
[3]   A TRYPANOSOMA-CRUZI SECRETED PROTEIN IMMUNOLOGICALLY RELATED TO THE COMPLEMENT COMPONENT-C9 - EVIDENCE FOR MEMBRANE PORE-FORMING ACTIVITY AT LOW PH [J].
ANDREWS, NW ;
ABRAMS, CK ;
SLATIN, SL ;
GRIFFITHS, G .
CELL, 1990, 61 (07) :1277-1287
[4]   TRANSFORMING GROWTH-FACTOR-BETA AS A VIRULENCE MECHANISM FOR LEISHMANIA-BRAZILIENSIS [J].
BARRAL, A ;
BARRALNETTO, M ;
YONG, EC ;
BROWNELL, CE ;
TWARDZIK, DR ;
REED, SG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3442-3446
[5]   The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure [J].
Belkaid, Y ;
Hoffmann, KF ;
Mendez, S ;
Kamhawi, S ;
Udey, MC ;
Wynn, TA ;
Sacks, DL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (10) :1497-1506
[6]  
Bennett CL, 2001, EUR J IMMUNOL, V31, P876, DOI 10.1002/1521-4141(200103)31:3&lt
[7]  
876::AID-IMMU876&gt
[8]  
3.0.CO
[9]  
2-I
[10]  
Blanchette J, 1999, EUR J IMMUNOL, V29, P3737, DOI 10.1002/(SICI)1521-4141(199911)29:11&lt